J. Goldman & Co’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-8,000
| Closed | -$161K | – | 283 |
|
|
2023
Q3 | $161K | Sell |
8,000
-27,983
| -78% | -$562K | 0.01% | 205 |
|
|
2023
Q2 | $966K | Buy |
+35,983
| New | +$966K | 0.04% | 167 |
|
|
2022
Q1 | – | Sell |
-18,283
| Closed | -$1.76M | – | 291 |
|
|
2021
Q4 | $1.76M | Buy |
18,283
+14,435
| +375% | +$1.39M | 0.1% | 160 |
|
|
2021
Q3 | $336K | Sell |
3,848
-63,149
| -94% | -$5.51M | 0.02% | 223 |
|
|
2021
Q2 | $10.4M | Sell |
66,997
-21,743
| -25% | -$3.37M | 0.4% | 41 |
|
|
2021
Q1 | $14M | Buy |
88,740
+71,291
| +409% | +$11.2M | 0.45% | 29 |
|
|
2020
Q4 | $4.05M | Buy |
17,449
+5,322
| +44% | +$1.24M | 0.21% | 98 |
|
|
2020
Q3 | $2.66M | Buy |
12,127
+5,377
| +80% | +$1.18M | 0.18% | 111 |
|
|
2020
Q2 | $1.92M | Buy |
6,750
+4,864
| +258% | +$1.38M | 0.12% | 125 |
|
|
2020
Q1 | $543K | Sell |
1,886
-350
| -16% | -$101K | 0.07% | 127 |
|
|
2019
Q4 | $643K | Sell |
2,236
-18,403
| -89% | -$5.29M | 0.05% | 135 |
|
|
2019
Q3 | $2.98M | Buy |
+20,639
| New | +$2.98M | 0.22% | 74 |
|